Physician profile
Candice E Shea
NPI 1548447170
$810.95
in general payments reported to CMS, 2019-2025
21 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $105 · 2021: $155 · 2022: $76.53 · 2023: $91.67 · 2024: $72.52 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $149.35 | 2019-2023 | Lo Loestrin Fe |
| Exeltis, USA INC. | $83.76 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $74.29 | 2022-2025 | |
| Astellas Pharma US INC | $71.74 | 2019-2024 | Veozah |
| Coopersurgical, INC. | $51.13 | 2019-2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $44.98 | 2025 | Myfembree |
| Therapeuticsmd, INC. | $36.86 | 2021 | |
| Millicent US INC | $34.02 | 2019-2025 | Femlyv |
| Evofem Biosciences, INC. | $30.64 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $27.79 | 2021 | |
| Avion Pharmaceuticals | $25.99 | 2019-2020 | |
| Stryker Corporation | $23.91 | 2025 | Mako |
| Urovant Sciences INC | $20.53 | 2022 | |
| Smith+Nephew, INC. | $18.89 | 2023 | Pico 14, Pico 7 |
| Myovant Sciences INC. | $18.79 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.61 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.26 | 2025 | |
| Duchesnay USA Incorporated | $17.41 | 2019 | |
| Minerva Surgical, INC | $15.06 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.63 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.